-
Full Article (HTML) (48) -
Full Article (PDF) (7)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5196)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2016 (publication date) through Jul 8, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Jaime Arellanes-Robledo, Karina Reyes-Gordillo, Joseph Ibrahim, Leslie Leckey, Ruchi Shah, M. Raj Lakshman. Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro. Biochemical Pharmacology 2018; 156: 135 doi: 10.1016/j.bcp.2018.08.021
|
| 2 |
Pan Jiang, Chaoqi Xu, Ming Zhou, Huaqun Zhou, Weida Dong, Xiaoyue Wu, Aochang Chen, Qing Feng. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC). Carcinogenesis 2018; 39(2): 252 doi: 10.1093/carcin/bgx138
|
| 3 |
LILIANA PASLARU, PETRUTA ALEXANDRU, SANDA M. CRETOIU, SIMONA O. DIMA, IRINEL POPESCU. CRISPR/Cas9 gene editing in Huh7 and Hepa RG cell lines. Romanian Biotechnological Letters 2019; 24(2): 216 doi: 10.25083/rbl/24.2/216.228
|
| 4 |
Jing Zhan, Liang-liang Shi, Yan Wang, Bai Wei, Sheng-li Yang. In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4738243
|
| 5 |
Ying Long, Miaolong Lu, Tingting Cheng, Xiaohan Zhan, Xianquan Zhan. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00835
|
| 6 |
Xinglong Qu, Ying Tang, Shucheng Hua. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00563
|
| 7 |
Chunmei Guo, Chao Gao, Dongting Zhao, Jiahui Li, Jinxia Wang, Xujuan Sun, Qinlong Liu, Lihong Hao, Frederick T. Greenaway, Yuxiang Tian, Shuqing Liu, Ming-Zhong Sun. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01559-1
|
| 8 |
Simone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, Luca Fabris. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World Journal of Hepatology 2017; 9(9): 455-468 doi: 10.4254/wjh.v9.i9.455
|
| 9 |
Kristy Chan, Regina Lo. Deregulation of Frizzled Receptors in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(1): 313 doi: 10.3390/ijms19010313
|
| 10 |
Yangyang Hu, Chao Deng, He Zhang, Jing Zhang, Bo Peng, Chuanyi Hu. Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer. Oncotarget 2017; 8(55): 94554 doi: 10.18632/oncotarget.21791
|
| 11 |
Wanhu Fan, Fenjing Du, Xiaojing Liu. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling. European Journal of Pharmacology 2019; 850: 109 doi: 10.1016/j.ejphar.2019.01.054
|
| 12 |
Silvia Zappavigna, Alessia Maria Cossu, Anna Grimaldi, Marco Bocchetti, Giuseppe Andrea Ferraro, Giovanni Francesco Nicoletti, Rosanna Filosa, Michele Caraglia. Anti-Inflammatory Drugs as Anticancer Agents. International Journal of Molecular Sciences 2020; 21(7): 2605 doi: 10.3390/ijms21072605
|
| 13 |
Norihiko Yamamoto, Akiko Eguchi, Yoshifumi Hirokawa, Suguru Ogura, Kazushi Sugimoto, Motoh Iwasa, Masatoshi Watanabe, Yoshiyuki Takei. Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2020; 39(2): 57 doi: 10.1089/mab.2019.0050
|
| 14 |
Dimitrios N Samonakis, Elias A Kouroumalis. Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World Journal of Hepatology 2017; 9(2): 80-90 doi: 10.4254/wjh.v9.i2.80
|
| 15 |
Melek Pehlivan, Ceyda Çalışkan, Zeynep Yüce, Hakki Ogun Sercan. Secreted Wnt antagonists in leukemia: A road yet to be paved. Leukemia Research 2018; 69: 24 doi: 10.1016/j.leukres.2018.03.011
|
| 16 |
Fei Cao, Li-Xue Yin. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Experimental and Molecular Pathology 2019; 106: 34 doi: 10.1016/j.yexmp.2018.10.009
|
| 17 |
Xiaowen Mao, Sze Keong Tey, Frankie Chi Fat Ko, Ernest Man Lok Kwong, Yi Gao, Irene Oi-Lin Ng, Siu Tim Cheung, Xin-Yuan Guan, Judy Wai Ping Yam. C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis. Cancer Letters 2019; 444: 60 doi: 10.1016/j.canlet.2018.12.003
|
| 18 |
Michael H Kagey, Xi He. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. British Journal of Pharmacology 2017; 174(24): 4637 doi: 10.1111/bph.13894
|
| 19 |
William P. Harris, Kit Man Wong, Supriya Saha, Imane El Dika, Ghassan K. Abou-Alfa. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers. Seminars in Oncology 2018; 45(3): 116 doi: 10.1053/j.seminoncol.2018.03.002
|
| 20 |
Juan Bayo, Esteban J. Fiore, Luciana M. Dominguez, Alejandrina Real, Mariana Malvicini, Manglio Rizzo, Catalina Atorrasagasti, Mariana G. García, Josepmaria Argemi, Elisabeth D. Martinez, Guillermo D. Mazzolini. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. Journal of Hepatology 2019; 71(1): 78 doi: 10.1016/j.jhep.2019.03.007
|
| 21 |
I. F. Kustova, A. S. Makarova, N. L. Lazarevich. Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy. Advances in molecular oncology 2019; 5(4): 8 doi: 10.17650/2313-805X-2018-5-4-8-19
|
| 22 |
Adewale Oluwaseun Fadaka, Ashwil Klein, Ashley Pretorius. In silico identification of microRNAs as candidate colorectal cancer biomarkers. Tumor Biology 2019; 41(11): 101042831988372 doi: 10.1177/1010428319883721
|